Redsense Medical ABRDSNF -51.43%54 Days Payable is 191.03 as of Mar. 2026, which is 85% above its 10-year median of 103.14. GuruFocus rates RDSNF with a GF Score™ of 54/100 and a GF Value™ of $0.77. The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Redsense Medical AB ranks better than 65.91% on this metric.
The historical rank and industry rank for Redsense Medical AB's Days Payable or its related term are showing as below:
RDSNF'
s Days Payable Range Over the Past 10 Years
Min: 41 Med: 103.14 Max: 349.33
Current: 102.2
During the past 13 years, Redsense Medical AB's highest Days Payable was 349.33. The lowest was 41.00. And the median was 103.14.
RDSNF's Days Payable is ranked better than 65.91% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs RDSNF: 102.20
Redsense Medical AB's Days Payable
increased
from Mar. 2025 (20.93) to Mar. 2026 (191.03).
It may suggest that Redsense Medical ABdelayed paying its suppliers.
Redsense Medical AB Days Payable Related Terms
Redsense Medical AB Days Payable Historical Data
* Premium members only.
The historical data trend for Redsense Medical AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Redsense Medical AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Redsense Medical AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Redsense Medical AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Redsense Medical AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Redsense Medical AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Redsense Medical AB (RDSNF) has a Days Payable of 191.03 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Redsense Medical AB and its competitors. This is 85% above median its historical median of 103.14. Over the past decade, Redsense Medical AB's Days Payable has ranged from 41.00 to 349.33. According to the industry distribution chart, Redsense Medical AB ranks #271 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 34.1%.
Is Redsense Medical AB's Days Payable too high?
Redsense Medical AB's current Days Payable of 191.03 is 85% above median its 10-year median of 103.14. Over the past 10 years, this metric has ranged from a low of 41.00 to a high of 349.33. The Medical Devices & Instruments industry median Days Payable is 67.87. Redsense Medical AB's value of 191.03 is 181.5% above this industry median. Based on the distribution chart, Redsense Medical AB ranks #271 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Redsense Medical AB has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Redsense Medical AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Redsense Medical AB ranks #271 out of 795 companies for Days Payable. This puts Redsense Medical AB in the upper half of its industry. The industry median Days Payable is 67.87. Redsense Medical AB's value of 191.03 is 181.5% above this benchmark. Historically, Redsense Medical AB's own Days Payable has ranged from 41.00 to 349.33 over the past decade. While the company's 10-year median is 103.14 vs. the industry median of 67.87, Redsense Medical AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Redsense Medical AB's current Days Payable of 191.03 is 181.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Redsense Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redsense Medical AB's current Days Payable is 191.03, which is 85% above median its own 10-year median of 103.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redsense Medical AB stock overvalued right now?
Redsense Medical AB (RDSNF) has a current Days Payable of 191.03. The stock's GF Value™ is $0.77, compared to a current price of $0.51 — trading 33.8% below its estimated fair value. The current Days Payable is 191.03, which is 85% above median its 10-year median of 103.14 and 181.5% above the Medical Devices & Instruments industry median of 67.87. Redsense Medical AB's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Redsense Medical AB (RDSNF), the current Days Payable is 191.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Redsense Medical AB (RDSNF) Overvalued in 2026?
Based on GuruFocus' analysis, Redsense Medical AB stock appears to be undervalued.
The current stock price of $0.51 is trading 33.8% below its estimated GF Value™ of $0.77.
Key valuation signals for RDSNF:
Days Payable: 191.03 (85% above median its 10-year median of 103.14)
GF Value™: $0.77 vs. price of $0.51 (33.8% below fair value)
Industry Position: 181.5% above the Medical Devices & Instruments median (#271 of 795)
No single metric tells the full story. See the RDSNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
54GF Score
Get the complete analysis for RDSNF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RDSNF has been successfully added to your 
